Fed Conditions
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal (NCT07333742) | LG Chem | 2025-09-29 |
| Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet® (NCT06103747) | Reseach Laboratory of Clinical and Experimental Pharmacology | 2023-02-21 |
| Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet® (NCT06073600) | Reseach Laboratory of Clinical and Experimental Pharmacology | 2022-05-20 |
| Fed Bioequivalence Study of CBZ Formulations (NCT02132897) | Center for Clinical Pharmacology Research Bdbeq S.A. | 2014-05-01 |
Track Fed Conditions automatically
Every clearance here is in the API, with alerts when new ones post.